Office of the Director, National Institutes of Health; Notice of Meeting, 50975 [E9-23721]
Download as PDF
<![CDATA[
Federal Register / Vol. 74, No. 190 / Friday, October 2, 2009 / Notices
50975
for conducting quarterly performance
testing plus periodic on-site inspections
of those LAPSA-accredited laboratories
was transferred to the U.S. HHS, with
the HHS NLCP contractor continuing to
have an active role in the performance
testing and laboratory inspection
processes. Other Canadian laboratories
wishing to be considered for the NLCP
may apply directly to the NLCP
contractor just as U.S. laboratories do.
Upon finding a Canadian laboratory to
be qualified, HHS will recommend that
DOT certify the laboratory (Federal
Register, July 16, 1996) as meeting the
minimum standards of the Mandatory
Guidelines published in the Federal
Register on April 13, 2004 (69 FR
19644). After receiving DOT
certification, the laboratory will be
included in the monthly list of HHScertified laboratories and participate in
the NLCP certification maintenance
program.
Suite 4000, Rockville, MD 20852, (301) 402–
8655, cm53v@nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page: https://
www.oar.nih.gov, where an agenda and any
additional information for the meeting will
be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.14, Intramural Research
Training Award; 93.22, Clinical Research
Loan Repayment Program for Individuals
from Disadvantaged Backgrounds; 93.232,
Loan Repayment Program for Research
Generally; 93.39, Academic Research
Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan
Repayment Program; 93.187, Undergraduate
Scholarship Program for Individuals from
Disadvantaged Backgrounds, National
Institutes of Health, HHS)
Contact Person: Alan L. Willard, PhD,
Scientific Review Administrator, Scientific
Review Branch, NINDS/NIH/DHHS,
Neuroscience Center, 6001 Executive Blvd,
Suite 3208, Msc 9529, Bethesda, MD 20892–
9529, (301) 496–5390,
willarda@ninds.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)
Elaine Parry,
Director, Office of Program Services,
SAMHSA.
[FR Doc. E9–23675 Filed 10–1–09; 8:45 am]
Dated: September 25, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–23721 Filed 10–1–09; 8:45 am]
Center for Scientific Review; Notice of
Closed Meetings
BILLING CODE 4160–20–P
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institutes of Health
Office of the Director, National
Institutes of Health; Notice of Meeting
pwalker on DSK8KYBLC1PROD with NOTICES
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the Office
of AIDS Research Advisory Council.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: Office of AIDS
Research Advisory Council.
Date: November 5, 2009.
Time: 8:30 a.m. to 5 p.m.
Agenda: The topic of the meeting will be
‘‘Opportunities for Research Collaborations
on HIV-Associated Comorbidities,
Coinfections, and Complications.’’ An update
also will be provided on the OARAC
Working Groups for HIV Treatment and
Prevention Guidelines.
Place: National Institutes of Health, 5635
Fishers Lane, Suite 4000, Rockville, MD
20852.
Contact Person: Christina Brackna,
Coordinator, Program Planning and Analysis,
Office of AIDS Research, Office of the
Director, NIH, 5635 Fishers Lane MSC 9310,
VerDate Nov<24>2008
16:40 Oct 01, 2009
Jkt 220001
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel; Conference Grant Review
Panel.
Date: November 11, 2009.
Time: 3 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852, (Virtual
Meeting).
PO 00000
Frm 00030
Fmt 4703
Sfmt 4703
Dated: September 25, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–23715 Filed 10–1–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Cancer Drug
Development and Therapeutics, SBIRISTTR.
Date: November 2–3, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.,
Place: Hilton Washington/Rockville, 1750
Rockville Pike, Rockville, MD 20852.
Contact Person: Hungyi Shau, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6186,
MSC 7804, Bethesda, MD 20892, 301–435–
1720, shauhung@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Computational Modeling and Sciences for
Biomedical and Clinical Applications.
Date: November 2, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.,
Place: The Allerton Hotel, 701 North
Michigan Avenue, Chicago, IL 60611.
Contact Person: Guo Feng Xu, PhD,
Scientific Review Officer, Center for
E:\FR\FM\02OCN1.SGM
02OCN1
]]>Agencies
[Federal Register Volume 74, Number 190 (Friday, October 2, 2009)]
[Notices]
[Page 50975]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-23721]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of the Director, National Institutes of Health; Notice of
Meeting
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of a meeting of the
Office of AIDS Research Advisory Council.
The meeting will be open to the public, with attendance limited to
space available. Individuals who plan to attend and need special
assistance, such as sign language interpretation or other reasonable
accommodations, should notify the Contact Person listed below in
advance of the meeting.
Name of Committee: Office of AIDS Research Advisory Council.
Date: November 5, 2009.
Time: 8:30 a.m. to 5 p.m.
Agenda: The topic of the meeting will be ``Opportunities for
Research Collaborations on HIV-Associated Comorbidities,
Coinfections, and Complications.'' An update also will be provided
on the OARAC Working Groups for HIV Treatment and Prevention
Guidelines.
Place: National Institutes of Health, 5635 Fishers Lane, Suite
4000, Rockville, MD 20852.
Contact Person: Christina Brackna, Coordinator, Program Planning
and Analysis, Office of AIDS Research, Office of the Director, NIH,
5635 Fishers Lane MSC 9310, Suite 4000, Rockville, MD 20852, (301)
402-8655, cm53v@nih.gov.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
Information is also available on the Institute's/Center's home
page: https://www.oar.nih.gov, where an agenda and any additional
information for the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.14,
Intramural Research Training Award; 93.22, Clinical Research Loan
Repayment Program for Individuals from Disadvantaged Backgrounds;
93.232, Loan Repayment Program for Research Generally; 93.39,
Academic Research Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan Repayment Program; 93.187,
Undergraduate Scholarship Program for Individuals from Disadvantaged
Backgrounds, National Institutes of Health, HHS)
Dated: September 25, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-23721 Filed 10-1-09; 8:45 am]
BILLING CODE 4140-01-M
